Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,240.0
5.5 (0.17%)

 

  • STI Straits Times Index
    3,240.0
    5.5 (0.17%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,574.4
    -3.5 (-0.22%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    27,940.5
    -
    Index delayed 15 minutes
  • SSE SSE Composite Index
    2,976.5
    -84.2 (-2.75%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    23,343.5
    -483.7 (-2.03%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,133.2
    -110.9 (-1.78%)
    Index delayed 10 minutes
  • KOR KOSPI
    2,246.1
    -21.1 (-0.93%)
    Index delayed 20 minutes
  • XAO XAO
    7,203.2
    4.2 (0.06%)
     

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 872.5M
  • Value: 729.1M
  • Rise: 113
  • Fall: 130
  • Unch: 575

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Medtecs Intl0.104-0.001
ThaiBev0.795+0.005
Rex Intl0.181+0.007
Spackman0.018+0.002
Golden Agri-Res0.225-
Genting Sing0.910-0.005
Joyas Intl0.003-
OEL0.023-0.001
YZJ Shipbldg SGD1.040-0.020
AusGroup^0.042+0.003

World Indices

World Indices
Name Last Change
Nasdaq 9,314.9 -87.6
HSI 27,940.5
HSCEI 10,969.3
Jakarta 6,133.2 -110.9
Nikkei 225 23,343.5 -483.7
SSE Comp 2,976.5 -84.2
Shanghai A 3,118.9 -88.2
Shanghai B 248.6 -8.9
PSE Comp 0.0
KOSPI 2,246.1 -21.1

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

EMERGENT BIOSOLUTIONS INC EMERGENT BIOSOLUTIONS
Updated on 24 Jan 2020 (End of trading day)
Last (USD): 56.020 Change: -2.090 High: 58.590 Remarks: -
Change (%): -3.60 Low: 55.820
Open 58.590 Yesterday's Close 58.11
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 275,815 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a 1.21455 Trailing EPS (USD) e 0.08329 NAV (USD) b 20.0488
PE a 46.124 Trailing PE f 672.553 Price / NAV b 2.7942
Dividend (USD) d - Cash In Hand (USD) g 2.7003 Issued & Paid-up Shares c 51,624,000
Dividend Yield (%) d - Price / Cash In Hand g 20.746 Treasury Shares h 1,200,000
Beta - 75 Daysi 0.771 R-Squared - 75 Days(%)i 3.97 Market Cap (M) 2,891.976
Beta - 500 Daysi 0.943 R-Squared - 500 Days (%)i 10.40 Enterprise Value (M) 3,595.876
Piotroski F Score 3 Exchange Code EBS Par Value ( $ ) n.a.
52 Weeks Volatility (%) 46.30 Free Float (%) 85.4
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 11 Nov 2019.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 25 Feb 2019.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference EMERGENT BIOSOLUTIONS INC NYSE 2,891.976 46.124 672.553 2.7942 -
Industry Biotechnology NYSE 5,449.612 18359.163 52.876 5.3655 0.580
Local Peer AGILENT TECHNOLOGIES INC NYSE 27,376.752 86.636 25.562 5.7660 0.692
Local Peer MYOVANT SCIENCES LTD NYSE 1,162.240 - - 67.3597 -
Local Peer KADMON HLDGS INC NYSE 713.372 - - 18.6717 -
Local Peer ARCUS BIOSCIENCES INC NYSE 430.157 - - 2.4272 -
Local Peer ENZO BIOCHEM INC NYSE 123.173 49.484 149.845 1.5726 -
Global Peer AMGEN INC NASDAQ 134,041.969 15.969 16.616 12.2671 2.480
Global Peer CSL ASX 141,021.137 52.562 52.563 18.8452 0.854
Global Peer GILEAD SCIENCES INC NASDAQ 79,894.223 14.646 29.667 3.8776 3.659
Global Peer AMGEN-T HKEx 594,184.000 9.032 9.399 6.9364 4.385
Global Peer VERTEX PHARMACEUTICAL NASDAQ 58,902.779 28.097 27.476 11.2123 -
Global Peer BIOGEN INC NASDAQ 50,188.138 11.327 9.302 3.5859 -
Global Peer ILLUMINA INC NASDAQ 46,978.260 56.874 48.282 10.5831 -
Global Peer REGENERON PHARMACEUTICALS INC NASDAQ 37,910.353 15.509 17.680 3.6090 -
Global Peer ALEXION PHARMACEUTICAL INC NASDAQ 23,295.304 300.197 15.844 2.2470 -
Global Peer SEATTLE GENETICS INC NASDAQ 19,464.308 - - 10.9374 -
Other Global Peers SINO BIOPHARM (HKEx), WUXI BIO (HKEx), INCYTE CORPORATION (NASDAQ), BIOMARIN PHARMACEUTICAL (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), EXACT SCIENCES CORP (NASDAQ), BEIGENE (HKEx), BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), 10X GENOMICS INC (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), MODERNA INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), EXELIXIS INC (NASDAQ), REPLIGEN CORP (NASDAQ), BLUEBIRD BIO INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), Lonza (SGX), GENSCRIPT BIO (HKEx), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), IMMUNOMEDICS INC (NASDAQ), NEKTAR THERAPEUTICS (NASDAQ), FIBROGEN INC (NASDAQ), 3SBIO (HKEx), AGIOS PHARMACEUTICALS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), ALKERMES PLC (NASDAQ), NATERA INC (NASDAQ), ACCELERON PHARMA (NASDAQ), KODIAK SCIENCES INC (NASDAQ), UNIQURE N.V. (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), SYNTHORX INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), EPIZYME INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), ARVINAS INC (NASDAQ), XENCOR INC (NASDAQ), VIELA BIO INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), INSMED INC (NASDAQ), ALECTOR INC (NASDAQ), REGENXBIO INC (NASDAQ), ALPHAMAB-B (HKEx), HAOHAI BIOTEC (HKEx), LIGAND PHARMACEUTICAL INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), CORTEXYME INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), VERACYTE INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), POLYNOVO LIMITED (ASX), COHERUS BIOSCIENCES INC (NASDAQ), NEXTCURE INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), MESOBLAST LTD (ASX), FRONTAGE (HKEx), ENANTA PHARMACEUTICALS INC (NASDAQ), CKLIFE SCIENCES (HKEx), OPKO HEALTH INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), DERMIRA INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), AVITA MEDICAL LTD (ASX), AVITA MEDICAL LTD SPON ADS EACH REP 20 ORD SHS (NASDAQ), XBIOTECH INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), INTREXON CORP (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), VIVA BIOTECH (HKEx), RADIUS HEALTH INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), ACHILLION PHARMACEUTICALS INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), IMMUNOGEN INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), OMEROS CORP (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), ASCENTAGE-B (HKEx), CYTOKINETICS INC (NASDAQ), RETROPHIN INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), NANTKWEST INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), AVROBIO INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), ARDELYX INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), NANOVIRICIDES INC (NYSE American), MACROGENICS INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), SINOMAB BIO-B (HKEx), AGENUS INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC ADS EACH REPR 6 SHS (SPONS) (NASDAQ), MERUS B V (NASDAQ), BELLUS HEALTH INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), TRANSLATE BIO INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), ASCLETIS-B (HKEx), RIGEL PHARMACEUTICALS INC (NASDAQ), CABALETTA BIO INC (NASDAQ), ESSEX BIO-TECH (HKEx), COMPUGEN (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), PROGENICS PHARMACEUTICALS INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), PDL BIOPHARMA INC (NASDAQ), PERSONALIS INC (NASDAQ), MANNKIND CORPORATION (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), RECRO PHARMA INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), IVERIC BIO INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), LEE'S PHARM (HKEx), STEMLINE THERAPEUTICS INC (NASDAQ), NEUROINSIGHTS NEUROTECH (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), DPHARMA (Bursa), SPECTRUM PHARMACEUTICALS INC (NASDAQ), MEDICINOVA INC (NASDAQ), NEXT SCIENCE LTD (ASX), KAMADA (NASDAQ), GERON CORP (NASDAQ), TELIX PHARMACEUTIC (ASX), PFENEX INC (NYSE American), WAVE LIFE SCIENCES LTD (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), NOVAVAX INC (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), BBI LIFE SCI (HKEx), VBI VACCINES INC CDA (NASDAQ), NAVIDEA BIOPHARMACEUTICALS INC (NYSE American), AFFIMED N V (NASDAQ), SERES THERAPEUTICS (NASDAQ), IMV INC (NASDAQ), ATHERSYS INC (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), XOMA CORP (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), NEUREN PHARMACEUTICALS LTD (ASX), GLYCOMIMETICS INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), CHIASMA INC (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), MONOPAR THERAPEUTICS INC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), CONTRAFECT CORP (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), ARAVIVE INC (NASDAQ), LINEAGE CELL THERAPEUTICS INC (NYSE American), X4 PHARMACEUTICALS INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), VERASTEM INC (NASDAQ), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), CEL-SCI CORP (NYSE American), SAVARA INC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), NEUROBO PHARMACEUTICALS INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), UNI-BIO GROUP (HKEx), RESAPP HEALTH LIMITED (ASX), PYC THERAPEUTICS LIMITED (ASX), AVALON GLOBOCARE CORP (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), ADURO BIOTECH INC (NASDAQ), AXCELLA HEALTH INC (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), CHIMERIX INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), VACCINEX INC (NASDAQ), COHBAR INC (NASDAQ), 22ND CENTURY GROUP INC (NYSE American), PALATIN TECHNOLOGIES INC (NYSE American), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), OTONOMY INC (NASDAQ), IMUGENE LIMITED (ASX), ACORDA THERAPEUTICS INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), SESEN BIO INC (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), TREVENA INC (NASDAQ), ORGENESIS INC (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), EQUILLIUM INC (NASDAQ), INFLARX N V (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), SYNLOGIC INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), VERMILLION INC (NASDAQ), CYNATA THERAPEUTICS LTD (ASX), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), IMMUTEP LTD (ASX), MICROBOT MEDICAL INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), ONCOSIL MEDICAL LIMITED (ASX), SYNTHETIC BIOLOGICS INC (NYSE American), NEWLINK GENETICS CORP (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), SOLIGENIX INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), ORTHOCELL LIMITED (ASX), KEZAR LIFE SCIENCES INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), CURIS INC (NASDAQ), CT ENTERPRISE (HKEx), T2 BIOSYSTEMS INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), INMUNE BIO INC (NASDAQ), ADVAXIS INC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), RESTORBIO INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), NEON THERAPEUTICS INC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), ISORAY INC (NYSE American), LEAP THERAPEUTICS INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), EVOGENE LTD (NASDAQ), ZAFGEN INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), INVEX THERAPEUTICS LTD NPV (ASX), ALIMERA SCIENCES INC (NASDAQ), BIOSINO BIO-TEC (HKEx), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), OCUGEN INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), BIOCARDIA INC (NASDAQ), BIOTRON (ASX), SEELOS THERAPEUTICS INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), UNUM THERAPEUTICS INC (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), AEVI GENOMIC MEDIC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), GENETIC TECHNOLOGIES (ASX), INNOVATE BIOPHARMACEUTICALS INC (NASDAQ), KAZIA THERAPEUTICS LIMITED (ASX), APTEVO THERAPEUTICS INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), ACTINOGEN MEDICAL LTD (ASX), ANTEOTECH LIMITED (ASX), REGENT PACIFIC (HKEx), BIONOMICS LTD (ASX), MEMPHASYS LTD (ASX), TALI DIGITAL LIMITED (ASX), ARMATA PHARMACEUTICALS INC (NYSE American), DARE BIOSCIENCE INC (NASDAQ), IBIO INC (NYSE American), ATYR PHARMA INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), VAXART INC (NASDAQ), SOPHIRIS BIO INC (NASDAQ), ORAGENICS INC (NYSE American), CCP TECHNOLOGIES LTD (ASX), EXTRAWELL PHAR (HKEx), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), RHINOMED LIMITED (ASX), INDIA GLOBALIZATION CAPITAL INC (NYSE American), ACTINIUM PHARMACEUTICALS INC (NYSE American), BIO-PATH HOLDINGS INC (NASDAQ), PROTEOMICS INTL LABORATORIES LTD (ASX), MIDATECH PHARMA PLC SPON ADS EACH REP 20 ORD SHS(R/S) (NASDAQ), CORREVIO PHARMA CORP (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), IMMURON LIMITED (ASX), PRECIPIO INC (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), PRESCIENT THERAPEUTICS LIMITED (ASX), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), CELLMID LIMITED (ASX), CLEVELAND BIOLABS INC (NASDAQ), PATRYS LIMITED (ASX), ENDRA LIFE SCIENCES INC (NASDAQ), Suntar Eco-City^ (SGX), CONATUS PHARMACEUTICALS INC (NASDAQ), CONTANGO ASSET MANAGEMENT LIMITED (ASX), TOCAGEN INC (NASDAQ), TROVAGENE INC (NASDAQ), BIOCEPT INC (NASDAQ), REGENEUS LTD (ASX), CYCLACEL PHARMA IN (NASDAQ), ADALTA LTD (ASX), ALTERITY THERAPEUTICS LIMITED (ASX), HOLISTA COLLTECH LIMITED (ASX), ACHIEVE LIFE SCIENCE INC (NASDAQ), ANATARA LIFESCIENCES LTD (ASX), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), SIENNA CANCER DIAGNOSTICS LTD (ASX), NOVABAY PHARMACEUTICALS INC (NYSE American), SENESTECH INC (NASDAQ), OPGEN INC (NASDAQ), AIM IMMUNOTECH INC (NYSE American), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), SENECA BIOPHARMA INC (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), REXAHN PHARMACEUTICALS INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), QT Vascular (SGX), LIVING CELL TECHNOLOGIES (ASX), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), HAO WEN HLDGS (HKEx), BENITEC BIOPHARMA LTD (ASX), AUSTRALIAN PRIMARY HEMP LTD (ASX), BENITEC BIOPHARMA LTD SPON ADS EA REPR 200 ORD SHS(POST SPLIT) (NASDAQ), BIOXYNE LIMITED (ASX), MEDIBIO LIMITED (ASX), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), MGRC (Bursa), SPHERIX INC (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ), TBG DIAGNOSTICS LTD (ASX), AVECHO BIOTECHNOLOGY LTD (ASX), NANOLLOSE LTD (ASX), THERAPIX BIOSCIENCES LTD SPON ADR EACH REP 40 ORD (POST SPLIT) (NASDAQ), AMPLIA THERAPEUTICS LTD (ASX), BPH ENERGY LIMITED (ASX), FACTOR THERAPEUTICS LIMITED (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+0.460
+0.83 %
10 Days -+1.470
+2.69 %
20 Days -+1.730
+3.19 %
Medium Term Return 3 Months --0.180
-0.32 %
6 Months -+12.450
+28.57 %
1 Year --3.550
-5.96 %
Long Term Return 2 Years -+5.290
+10.43 %
3 Years -+26.300
+88.49 %
5 Years -+29.546
+111.60 %
Annualised Return Annualised --
+16.17 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 39.110 - 67.450 Change From 1 Year Low +16.910 % Change From 1 Year Low (%) +43.24
Change From 1 Year High -11.430 % Change From 1 Year High (%) -16.95
2 Years Range 39.110 - 73.890 Change From 2 Years Low +16.910 % Change From 2 Years Low (%) +43.24
Change From 2 Years High -17.870 % Change From 2 Years High (%) -24.18
5 Years Range 24.470 - 73.890 Change From 5 Years Low +31.550 % Change From 5 Years Low (%) +128.93
Change From 5 Years High -17.870 % Change From 5 Years High (%) -24.18
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Emergent BioSolutions Inc. engages in the development, manufacture, and commercialization of medical countermeasures. It offers specialty products for civilian and military populations that address accidental, intentional and naturally occurring public health threats. Its business units include Vaccines and Anti-Infectives; Antibody Therapeutics; Devices; and Contract Development and Manufacturing. The company was founded by Fuad El-Hibri in May 1998 and is headquartered in Gaithersburg, MD.

Historical Price Data

Date Open High Low Close Volume VWAP
24 Jan 2020 58.590 58.590 55.820 56.020 275,815 -
23 Jan 2020 58.490 58.680 57.280 58.110 239,606 -
22 Jan 2020 57.320 59.580 57.320 58.440 285,673 -
21 Jan 2020 55.330 57.580 54.810 57.320 331,930 -
17 Jan 2020 56.040 56.060 55.270 55.560 254,857 -
16 Jan 2020 55.000 56.070 54.780 56.040 240,554 -
15 Jan 2020 54.940 56.045 54.550 54.960 279,272 -
14 Jan 2020 54.620 55.490 53.850 55.250 225,135 -
13 Jan 2020 55.540 55.975 54.040 54.550 377,582 -
10 Jan 2020 56.680 58.140 55.490 55.700 818,597 -
09 Jan 2020 55.470 56.680 54.805 56.680 303,360 -
08 Jan 2020 54.200 55.260 53.960 55.060 233,816 -
07 Jan 2020 54.730 55.225 53.750 54.080 224,658 -
06 Jan 2020 53.720 54.990 53.195 54.970 233,994 -
03 Jan 2020 53.240 54.290 52.640 54.240 451,674 -
02 Jan 2020 54.270 54.365 52.500 54.000 222,070 -
31 Dec 2019 54.050 55.120 53.870 53.950 212,733 -
30 Dec 2019 54.100 55.305 53.880 54.290 194,249 -
27 Dec 2019 54.490 54.700 53.380 54.000 238,230 -
26 Dec 2019 56.010 56.010 54.160 54.230 206,662 -
24 Dec 2019 55.220 56.390 54.850 55.860 120,816 -
23 Dec 2019 54.650 55.280 53.750 54.960 308,319 -
Summary
Current 2 Weeks
(10 Jan 2020 to 24 Jan 2020)
56.680 59.580 53.850 56.020 3,329,021 -
Previous 2 Weeks
(26 Dec 2019 to 09 Jan 2020)
56.010 59.580 53.850 56.680 2,521,446 -
4 Weeks from
(26 Nov 2019 to 24 Dec 2019)
54.530 59.580 53.510 55.860 6,639,216 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.